Navigation Links
Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
Date:1/24/2008

Portrait because you can heat 100% of the surface and dermis uniformly."

For patients who are not interested in (or good) candidates for surgery, Dr. Biesman recommends Portrait Plasma as a stand alone procedure. "For patients who have moderately droopy, loose, or wrinkled skin, surgery may not be the best option, but Portrait Plasma may be," Dr. Biesman explains. In a study conducted by Dr. Biesman looking at the use of high energy Portrait Plasma skin regeneration compared to blepharoplasty, patients rated their overall improvement with Portrait Plasma as 64%. Dr. Biesman said of his reaction to the initial results, "I am very, very enthusiastic about the changes we are seeing...plasma treatment of the eyelid is a very viable and I think a very exciting technique that can play a nice role in the aesthetic practice." Portrait Plasma now offers patients a number of new treatment options for tightening and significant wrinkle improvement without surgery.

Portrait Plasma harnesses the power of plasma to deliver dramatic skincare results without the risk or down time associated with outdated laser procedures. The hand-piece delivers nitrogen plasma energy that works both at and below the surface of the skin to modify its architecture and generate new collagen for up to two years. Portrait PSR3 has been proven to treat fine lines and deep wrinkles, sun damage and pre-cancerous lesions and dyschromia. It also improves pore size, elasticity, and tone and texture of the face and body.

This in-office procedure takes 20 - 30 minutes for a full face or a targeted body treatment. Localized procedures around the eyes and mouth can be done in as little as 10 to 15 minutes. There is no additional downtime when blepharoplasty and/or injectables and fillers are used in conjunction with Portrait Plasma.

About Rhytec - The Makers of Portrait Plasma:

Rhytec develops innovative plasma technologies based on sound scientific and clinical research for th
'/>"/>

SOURCE Rhytec, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
2. GSK Does Not Option XL784 for Further Development
3. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
4. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
5. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
6. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
7. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
8. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
9. Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
10. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
11. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)...  Ascendant Solutions, Inc. (Pink Sheets: ASDS ) ... subsidiary, Dougherty,s Holdings, has acquired Springtown Drug (" ... Springtown, Texas , just north of ... pharmacy has provided retail prescriptions, healthcare products and gifts ... . The Springtown ...
(Date:8/31/2015)... Pa. , Aug. 31, 2015 The ... reversed statewide since Pennsylvania State ... life-saving drug kits, naloxone. Heroin and opioid ... Pennsylvania , killing more individuals than ... approximately 2,400 Pennsylvanians died from a drug overdose. ...
(Date:8/31/2015)... Regen BioPharma, Inc. (OTCBB: RGBP) and ... means of delivering its patented (US Patent 8,263,571) ... utilizing a clinically approved formulation as delivery system.  ... gene silencing therapeutics in which the gene silencing ... body.  By utilizing a local delivery system, potential ...
Breaking Medicine Technology:Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 2Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 3Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 2Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 3Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3
... One of the more difficult aspects of planning ... resource and investment allocations that are needed to prepare ... wrestle with allocating the appropriate resources for informing key ... are carried out across different functional areas. ...
... Floridians turned in nearly 5,500 pounds of prescription and ... enforcement offices throughout the state during the Drug Take ... the amount dropped off at 38 sites last year. ... National Association of Drug Diversion Investigators (NADDI) ...
Cached Medicine Technology:Study Uncovers Key Success Factors and Common Failure Points for Launching New Metabolic Products in Today's Competitive Healthcare Market 2NADDI and the C.A.R.E.S. Alliance Co-Sponsor Successful Drug Take Back Day 2
(Date:8/31/2015)... ... August 31, 2015 , ... ... was formed in 2008, the result of a merger of five of the ... working cooperatively, they could provide more cost-effective and higher quality care than they ...
(Date:8/31/2015)... ... ... Presents, Dr. Michael Betsy! Dr. Betsy has been reviewed and approved as an “NJ ... Don Bosco Prep in 1990 and was Class Salutatorian. He earned Varsity letters in ... year. He was inducted into the National Honor Society as a sophomore, was an ...
(Date:8/31/2015)... Nashville, TN (PRWEB) , ... August 31, 2015 , ... ... and how it may be prevented during Amblyopia Awareness Month. Only a comprehensive eye ... is the most common cause of visual impairment among children, affecting approximately 2 to ...
(Date:8/31/2015)... ... August 31, 2015 , ... Diablo Publications ... that it has officially launched a new website and company identity ( diablopublications.com) ... are more closely aligned with the company’s strategic vision for growth and expansion ...
(Date:8/31/2015)... ... , ... Three Bakers Gluten Free Bakery launched the redesign of its website, ... information on their offering of gluten-free breads and pizzas, living without gluten, and resources ... us to share information about our gluten free product offerings, but also to really ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Garden State Urology! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 3Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3Health News:Three Bakers Gluten Free Bakery Announces Launch of New Website 2
... today reveals that California ranks in the bottom half of ... District of Columbia in the percentage of children who ... "Reading Across the Nation: A Chartbook," prepared by the UCLA ... Reach Out and Read National Center, only 44.6 percent of ...
... published today in a special supplement to the Journal of ... for patients who speak little, if any, English and the ... settings. The studies overall report that measurable disparities in quality ... the same language. , Hospitalized Patients ...
... for Grand Wine Tasting on Friday ... TALLAHASSEE, Fla., Nov. 1 The 12th Annual Tallahassee,Wine ... featuring more than 200 wines from around the world, including,unique ... off at 6 p.m. with three fun-filled sessions about wine:, ...
... is the most common,widespread chronic pain condition in ... But, findings from two new surveys commissioned by,the ... much to be,learned about this debilitating condition. ... half (45%) of respondents,have never heard of fibromyalgia. ...
... Addition to Postal Service Social Awareness Stamp,Series, WASHINGTON, ... next year to help raise awareness about Alzheimer,s disease,as ... John,Potter announced today, on the first day of both ... "With the Alzheimer,s Awareness commemorative stamp, we,ll ask,Americans ...
... 1 NexGenix Pharmaceuticals, a privately,held biotechnology company ... tumor suppressor disorder neurofibromatosis and related sporadic,tumors, today ... of NexGenix will be presenting at the Acumen ... at 3:00 pm on November 5th, 2007,at the ...
Cached Medicine News:Health News:Report shows less than half of kids in California are being read to daily 2Health News:Report shows less than half of kids in California are being read to daily 3Health News:JGIM: studies show importance of language services on disparities, quality of care 2Health News:JGIM: studies show importance of language services on disparities, quality of care 3Health News:JGIM: studies show importance of language services on disparities, quality of care 4Health News:JGIM: studies show importance of language services on disparities, quality of care 5Health News:Take a Culinary Trip Around the World for a Good Cause: March of Dimes 2Health News:Medialink Features: The Painful Truth About Fibromyalgia 2Health News:Alzheimer's Disease to be Highlighted on Stamp Next Year 2Health News:NexGenix Pharmaceuticals to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: